Dentsply Sirona Inc. wins Summary Judgment against Edge Endo and US Endodontics in Patent Infringement Case
Dentsply Sirona (Nasdaq: XRAY) announced a ruling on June 23, 2020, by the U.S. District Court for New Mexico, confirming that EdgeTaper Encore endodontic files infringe on three valid patents owned by Dentsply Sirona. The court also dismissed a request from Edge to dismiss claims of willful infringement, which could lead to treble damages. A trial is scheduled to begin on August 17, 2020, to address Dentsply Sirona's claims for willful infringement and damages related to additional patent claims.
- Court ruling affirms patent validity and infringement, strengthening Dentsply Sirona's IP position.
- Potential for treble damages if infringement found to be willful, enhancing financial recovery opportunities.
- Trial uncertainty may affect investor confidence pending resolution on additional patent claims.
- -
CHARLOTTE, N.C., June 24, 2020 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), The Dental Solutions Company, today announced that on Tuesday, June 23rd, 2020 the United States District Court for the District of New Mexico, in a ruling by Judge Joseph F. Bataillon, held that EdgeTaper Encore endodontic files sold by US Endodontics and Edge Endo infringe at least three valid claims of patents asserted by Dentsply Sirona Inc. Judge Bataillon granted Dentsply Sirona’s motion for summary judgment that each of the three patent claims were infringed by EdgeTaper Encore and that Dentsply Sirona’s three patent claims are valid. The Court also rejected Edge’s request to dismiss Dentsply Sirona’s claim that Edge’s infringement was willful. A finding of willful infringement allows the Court to award treble damages and attorneys’ fees against an adjudicated infringer.
Dentsply Sirona’s case against Edge and US Endo is scheduled for trial before a jury in Albuquerque, New Mexico beginning on August 17, 2020. At issue will be Dentsply Sirona’s claims for willful infringement and damages with respect to the three claims that have already been held valid and infringed, as well as Dentsply Sirona’s assertion of infringement with respect to additional patent claims.
About Dentsply Sirona
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 133-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental equipment and dental consumable products under a strong portfolio of world class brands. The Company also manufactures and markets healthcare consumable products. As The Dental Solutions Company, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry. The Company’s shares of common stock are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
Contact Information:
Investors:
John Sweeney, CFA, IRC
Vice President, Investor Relations
+1-717-849-7863
John.Sweeney@dentsplysirona.com
Media:
Marion Par-Weixlberger
Vice President Public Relations & Corporate Communications
T +43 (0) 662 2450-588
marion.parweixlberger@dentsplysirona.com
FAQ
What did the U.S. District Court rule regarding Dentsply Sirona and EdgeTaper Encore?
What are the implications of the court's ruling for Dentsply Sirona?
When is the trial for Dentsply Sirona against Edge and US Endo?
What could happen if willful infringement is established in the trial?
What does Dentsply Sirona specialize in?
